tirzepatide and hypertension Tirzepatide's Association With BP Reduction Reinforced With ABPM Data Call to action for drug
Description
Tirzepatide is administered via a small subcutaneous injection once per week

[DOI] [PMC free article] [PubMed] [Google Scholar] 274.Kim D.D., Hwang J.H., Fendrick A.M

Chin J Circu

Patent expirations are also reshaping the market

In response, we retrospectively evaluated the efficacy and safety of oral semaglutide at a dose of 14 mg for obesity treatment in this population